23 Feb 2017 08:53
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Dechra Pharmaceuticals plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √ | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | √ | ||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to thenotification obligation: iii | Aviva plc & its subsidiaries | ||||
4. Full name of shareholder(s) Â (if different from 3.):iv | Registered Holder: Â Chase (GA Group) Nominees Limited2,070,968* Â Chase Nominees Limited21,988* HSBC Global Custody Nominee (UK) Limited494,541*Street Nominees Limited227,684* Available Upon Request7,446* * denotes direct interest | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 21 February 2017 | ||||
6. Date on which issuer notified: | 22 February 2017 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 3% Change at Direct Interest Level | ||||
Â
8. Notified details: | |||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
Ordinary SharesGB0009633180 | Below Threshold | Below Threshold | 2,822,627 | 2,822,627 | Not Disclosable | 3.03% | Not Disclosable | ||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||
RIGHT TO RECALL LOANED SHARES | N/A | N/A | 159,637 * Â * Direct Interest | 0.17% | |||||||
Â
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to  | % of voting rights xix, xx  | |
   | Nominal | Delta | ||||
Â
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
2,982,264 | 3.20% |
Â
Â
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | |
The voting rights are managed and controlled by Aviva Investors Global Services Limited and Friends Provident International Limited, with the following chains of controlled undertakings:-  Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)  Friends Provident International Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Friends Provident International Limited (wholly owned subsidiary of Aviva Group Holdings Limited)  | |
Proxy Voting: | |
10. Name of the proxy holder: | See Section 4 |
11. Number of voting rights proxy holder will ceaseto hold: | |
12. Date on which proxy holder will cease to holdvoting rights: |
Â
13. Additional information: | Figures are based on a total number of voting rights of 93,059,190 as per the Company's Total Voting Rights Announcement of 31 January 2017. |
14. Contact name: | Neil Whittaker, Aviva plc |
15. Contact telephone number: | 01603 684420 |
Â